Yue Wang

6PUBLICATIONS
9CO-AUTHORS
Medical mycologyHaematological tumoursMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.

|May 20, 2025
GATA1: A key biomarker for predicting the prognosis of patients with diffuse large B-cell lymphoma.

Yuxin Zhang, Yue Wang, Shifen Wang

|Apr 08, 2025
LRP8-dependent cholesterol metabolism modulates mTORC1 signaling and apoptotic pathways in multiple myeloma.

Yue Wang, Tianwei Lan, Chi Zhou

|Feb 06, 2025
Myeloma cell-derived CXCL7 facilitates proliferation of tumor cells and occurrence of osteolytic lesions through JAK/STAT3 pathway.

Yue Wang, Tianwei Lan, Qiongyan Zhang

|Nov 15, 2023
The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.

Yue Wang, Jiadai Xu, Tianwei Lan

|Dec 12, 2018
Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer.

Yun-Jie Yang, Yun-Yi Kong, Gao-Xiang Li

Pageof 1

Frequent Collaborators

4 joint publications

Peng Liu

1 joint publications

Bo Dai

1 joint publications

Yuxin Zhang

1 joint publications

Shifen Wang